Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

JAK inhibitors show promise in treating moderate to severe alopecia areata.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Tryptanthrin effectively suppresses non-melanoma skin cancer and is safe for normal skin.

New therapies are being developed that target integrin pathways to treat various diseases.

IL-1β inhibits human hair follicle growth.

Tofacitinib is effective and safe for treating alopecia areata.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.

Tofacitinib may help treat severe hair loss, but more research is needed.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Three compounds from Dadap leaves may help treat hair loss.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

The Itpr3 gene causes a specific hair pattern in mice.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib taken by mouth helps treat hair loss in children.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.